colistimethate sodium has been researched along with pipemidic acid in 1 studies
Studies (colistimethate sodium) | Trials (colistimethate sodium) | Recent Studies (post-2010) (colistimethate sodium) | Studies (pipemidic acid) | Trials (pipemidic acid) | Recent Studies (post-2010) (pipemidic acid) |
---|---|---|---|---|---|
188 | 12 | 140 | 269 | 32 | 37 |
Protein | Taxonomy | colistimethate sodium (IC50) | pipemidic acid (IC50) |
---|---|---|---|
exodeoxyribonuclease V subunit RecB | Escherichia coli str. K-12 substr. MG1655 | 0.1 | |
exodeoxyribonuclease V subunit RecC | Escherichia coli str. K-12 substr. MG1655 | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K | 1 |
1 trial(s) available for colistimethate sodium and pipemidic acid
Article | Year |
---|---|
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Colistin; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Nicotinic Acids; Nystatin; Pipemidic Acid; Pneumonia; Random Allocation | 1989 |